Newsletter registration

Используя наш сайт, Вы соглашаетесь с тем, что в целях обеспечения оптимального сервиса на Вашем компьютере будут сохраняться файлы Cookie и будет использоваться служба Google Analytics. Более подробную информацию об этом Вы найдетездесь.
Австрия
Мост к новым рынкам

Oral vaccination for type 1 diabetes may be possible

In the case of type 1 diabetes, the autoimmune response against the insulin-producing cells in the pancreas leads to an outbreak of the illness.   An international group of scientists including doctors from the University Pediatric Clinic in Vienna investigated a type of prophylactic vaccine against diabetes. The results were positive, as reported in the American medical journal “JAMA”.

"In this study with children with a high risk of developing type 1 diabetes, the oral administration of 67.5 milligrams of insulin once per day compared to a placebo led to an immune response without the corresponding development of low blood sugar. The results show that a Phase III study (note: effectiveness) would be recommended in order to determine whether insulin can prevent the autoimmune response against the islet cells and thus diabetes in such children”, said  Ezio Bonifacio of the Center for Regenerative Meidince at the Dresden University of Technology and his co-authors in summarizing the results of the study.   

The publication is a so-called pre-POINT study, involving the Center for Childhood Diabetes at the University of Colorado (Denver, USA), Southmead Hospital (Bristol, UK), the University Pediatric Clinic at Vienna General Hospital (Medical University of Vienna), the research facility in Dresden and the Institute for Diabetes Research of the Munich University of Technology. The specialists Edith Schober and Birgit Rami from Vienna participated in the project.

The work could be pioneering, according to Anette-Gabriele Ziegler of the Institute for Diabetes Research in Munich. The attempt to develop a prophylactic vaccine to prevent autoimmune responses triggering “juvenile diabetes” is unique. “This is a revolutionary approach to prevent type 1 diabetes“, she said. A more extensive study to precisely clarify the effectiveness of this approach is planned.  In this case, the plan is to target families in which type 1 diabetes often occurs. 

Share on Facebook Share on Facebook Share on Twitter Share on Twitter

Отзывы

Мероприятия

Познакомьтесь с нами в рамках мероприятий, семинаров и выставок по всему миру

Austria Map

Find the perfect location for your company

Выбор столицы Австрии в качестве места учреждения первого зарубежного офиса Национального Рейтингового Агентства абсолютно не случаен. У Австрии и России давнишняя история дружественных и взаимовыгодных отношений. И сейчас Австрия для России остается одним из самых комфортных и дружелюбных партнеров в ЕС.

Национальное Рейтинговое Агентство

Logo Национальное Рейтинговое Агентство
Все отзывы

Новости Австрии, как площадки для бизнеса

September 12-14, 2018: 1MillionStartups Global Conference in Vienna

The Viennese startup hub weXelerate is hosting the very first 1MillionStartups Global Conference from September 12-14, 2018.

Testing the potential early detection of ovarian cancer

About 75 percent of the cases of extremely aggressive ovarian cancer (ovarian carcinoma) originally arise in the fallopian tube. Currently there are no possibilities to detect this at an early stage. A new catheter system developed by Viennese scientists could represent a new possibility to deal with this.

Все новости